Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development

Pediatrics

Volumn 122, Issue 2, 2008, Pages 340-346

  Janér, Joakim ^a,b   Andersson, Sture ^a   Haglund, Caj ^a   Karikoski, Riitta ^a   Lassus, Patrik ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bronchopulmonary dysplasia; Lung development; Neonatal; Respiratory

Indexed keywords

IMMUNOGLOBULIN A; LACTOSYLCERAMIDE; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR;

ACUTE LUNG INJURY; ARTICLE; BRONCHUS MUCOSA; CHORIOAMNIONITIS; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG DEVELOPMENT; LYMPH VESSEL ENDOTHELIUM; MACROPHAGE; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME; TISSUE LEVEL; VASCULAR ENDOTHELIUM; CASE CONTROL STUDY; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; INCIDENCE; LUNG; LUNG DYSPLASIA; LUNG LAVAGE; METABOLISM; NONPARAMETRIC TEST; PRENATAL DEVELOPMENT; PROBABILITY; REFERENCE VALUE; REGRESSION ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PREGNANCY PROTEINS; PROBABILITY; REFERENCE VALUES; REGRESSION ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 49849098334     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1941     Document Type: Article

References (36)

1. Maglione D, Guerriero V, Viglietto G, Delli-BoviP, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 1991;88(20):9267-9271
2. Ylä-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med. 2003;9(6):694-701
3. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6(9): 1677-1683
4. Wise LM, Veikkola T, Mercer AA, et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 andneuropilin-1. Proc Natl Acad Sci USA. 1999;96(6): 3071-3076
5. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 2001;49(3):568-581
6. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to flt-1 but not to flk-1/KDR. J Biol Chem. 1994;269(41): 25646-25654
7. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13(1):9-22
8. Shibuya M, Ito N, Claesson-Welsh L. Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr Top Microbiol Immunol. 1999;237:59-83
9. Cao Y, Linden P, Shima D, Browne F, Folkman J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest. 1996;98(11):2507-2511
10. Zoban P, Cerny M. Immature lung and acute lung injury. Physiol Res. 2003;52(5):507-516
11. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641-643
12. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis." Am J Respir Crit Care Med. 2001;164(10):1755-1756
13. Akeson AL, Cameron JE, Le Cras TD, Whitsett JA, Greenberg JM. Vascular endothelial growth factor-A induces prenatal neovascularization and alters bronchial development in mice. Pediatr Res. 2005;57(1):82-88
14. Compernolle V, Brusselmans K, Acker T, et al. Loss of HTF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8(7):702-710
15. Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S. Vascular endothelial growth factor in the human preterm lung. Am J Respir Crit Care Med. 1999;159(5):1429-1433
16. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527-532
17. Lassus P, Turanlahti M, Heikkila P, et al. Pulmonary endo- thelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 2001; 164(10):1981-1987
18. Watts CL, Fanaroff AA, Bruce MC. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr. 1992;120(4):614-620
19. Hallman M, Bry K, Pitkanen O. Ceramide lactoside in amniotic fluid: high concentration in chorioamnionitis and in preterm labor. Am J Obstet Gynecol. 1989;161(2):313-318
20. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7(5):575-583
21. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389-395
22. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol. 2004;190(1):147-151
23. Jobe AH. Glucocorticoids, inflammation and the perinatal lung. Semin Neonatol. 2001;6(4):331-342
24. Turunen R, Nupponen I, Siitonen S, Repo H, Andersson S. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Pediatrics. 2006;117(2):448-454
25. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood- island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376(6535):62-66
26. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996;15(2):290-298
27. Dumont DJ, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998; 282(5390):946-949
28. Mäkinen T, Veikkola T, Mustjoki S, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 2001; 20(17):4762-4773
29. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 1999;86(11):2406-2412
30. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angio- genic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6):1163-1177
31. Hiratsuka S, Kataoka Y, Nakao K, et al. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol. 2005;25(1):355-363
32. Hosford GE, Olson DM. Effects of hyperoxia on VEGF, its receptors, and HTF-2α in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol. 2003;285(1):L161-L168
33. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12(11):1286-1293
34. Ambalavanan N, Novak ZE. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res. 2003;53(2):240-244
35. Asikainen TM, Ahmad A, Schneider BK, White CW. Effect of preterm birth on hypoxia-inducible factors and vascular endo- thelial growth factor in primate lungs. Pediatr Pulmonol. 2005; 40(6):538-546
36. De Paepe ME, Mao Q, Powell J, et al. Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. 2006;173(2):204-211